Quest Diagnostics (DGX) Operating Income (2009 - 2026)

Quest Diagnostics has disclosed Operating Income across 18 years of filings, most recently posting $459.0 million for Q2 2026.

• In Q2 2026, Operating Income rose 4.79% year-over-year to $459.0 million; the TTM figure through Jun 2026 stood at $1.6 billion (up 10.51% YoY), while the FY2025 annual figure was $1.6 billion, up 15.6% from the prior year.
• Operating Income came in at $459.0 million for Q2 2026 at Quest Diagnostics, up from $399.0 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of $513.0 million in Q1 2022 to a low of $135.0 million in Q4 2022.
• Average Operating Income over 5 years is $358.3 million, with a median of $358.0 million recorded in 2024.
• Year-over-year, Operating Income tumbled 74.81% in 2022 and surged 97.78% in 2023.
• Over 5 years, Operating Income stood at $135.0 million in 2022, then jumped by 97.78% to $267.0 million in 2023, then soared by 35.21% to $361.0 million in 2024, then increased by 6.93% to $386.0 million in 2025, then climbed by 18.91% to $459.0 million in 2026.
• Per Business Quant data, the three most recent Operating Income figures were $459.0 million in Q2 2026, $399.0 million in Q1 2026, and $386.0 million in Q4 2025.